BeiGene to Invest $19.5 Million in Bravera’s Series A RoundCoinLive·Nov 16, 2026 at 10:20 AMONC-0.88%06160-0.16%
Weekly Recap | Beigene +2.35%, closing in on record highsWeekly Review·Nov 14, 2026 at 06:52 AMONC-0.88%
BeOne Medicines hits record high in premarket on drug priority reviewMarket Movers·Nov 11, 2026 at 09:14 AMONC-0.88%
BeOne Medicines Ltd (6160) Gets a Buy from DaiwaTip Ranks·Nov 11, 2026 at 01:05 AMONC-0.88%06160-0.16%
Daiwa Raises BEONE MEDICINES TP to USD476 as 3Q Again Beats Expectations and Guidance RaisedAASTOCKS News·Nov 10, 2026 at 06:00 AMONC-0.88%06160-0.16%
CLSA Raises BEONE MEDICINES TP to HKD336.8, 3Q Results Beat ExpectationsAASTOCKS News·Nov 10, 2026 at 03:10 AMONC-0.88%06160-0.16%
BeOne Medicines (ONC) Priority Review And Earnings Put Valuation Back In FocusSimplywall·Nov 9, 2026 at 01:48 PMONC-0.88%06160-0.16%
Citi Raises BeOne Medicines Ltd. TP to USD507 as Quarterly Revenue Beats ForecastsAASTOCKS News·Nov 9, 2026 at 06:26 AMONC-0.88%06160-0.16%
Beigene (ONC) hit a 52-week high in after-hours trading, currently at $411.83, up approximately 1%Market Movers·Nov 9, 2026 at 01:33 AMONC-0.88%
Why BeOne Medicines Stock Is In Focus After Earnings Beat And Raised GuidanceSimplywall·Nov 7, 2026 at 10:43 AMONC-0.88%
Weekly Recap | Beigene +9.89%, earnings beat and guidance raisedWeekly Review·Nov 7, 2026 at 08:36 AMONC-0.88%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Nov 6, 2026 at 09:05 PMELVN-2.64%KPTI0.00%
Wells Fargo maintains BeOne Medicines at Overweight, raises price target to $435 from $400TradingView·Nov 6, 2026 at 02:51 PMONC-0.88%